• Postoperative residual neuromuscular blockade is associated with post-op complications
• Current blockade reversal agents are Sugammadex and Neostigmine
• Sugammadex may decrease postoperative residual neuromuscular blockade
• Sugammadex was introduced to UC Davis Academic Center on 3/11/16
